Arduino has recently introduced a new Bluetooth-based provisioning flow on the Arduino Cloud, starting with the UNO R4 WiFi ...

Let your creativity shine: Is $249/month Google Gemini Ultra text-to-video tool worth it? The AI race is wild, with no rulebook. In this world-without-rules, anyone can be a creator. That's the ...

BRANFORD, Conn., Aug. 27, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision ...

Nano Labs (NASDAQ:NA) has entered into an at-the-market offering agreement to sell its shares of Class A ordinary shares having an aggregate offering price of up to $45M. Net proceeds from the sale ...

ALLENTOWN, Pa. - A woman charged with falsely reporting to police that someone left a noose on her workplace desk has been accepted into a first-time offender program. Lehigh County District Attorney ...

Arduino has created a Renesas RA4M1 microcontroller board in its Nano form-factor. Called Nano R4, it follows the Uno R4, the first Arduino to use the RA4M1. “Whether you’re working on a connected ...

PRIME Central Coast builds on several UC Santa Cruz programs designed to help address California’s growing healthcare crisis and reflects the campus’s ever-expanding commitment to supporting the needs ...

New York, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on ...

Hi, I'm Bill. I'm a software developer with a passion for making and electronics. I do a lot of things and here is where I document my learning in order to be able to inspire other people to make ...

NANO Nuclear Energy Inc. has launched a significant two-year irradiation testing program in partnership with the Massachusetts Institute of Technology (MIT) to analyze the behavior of nitrate molten ...

Rallybio ended the RLYB212 FNAIT program after Phase 2 data showed drug levels failed to reach target concentration for efficacy. Dosing of RLYB116, Rallybio’s C5 inhibitor, starts in Q2 2025 with ...